Christos Lionis

Christos Lionis is a medical doctor and Professor with a strong interest in primary care and public health education, practice, and research. Christos has served the Clinic of Social and Family Medicine (CSFM) at the School of Medicine, University since 1995 (March) as a Professor of General Practice and Primary Health Care and CFSM Director until August 2022. In January 2023, Christos was appointed Professor Emeritus of the University of Crete. He is also designated as a Guest Professor of General Practice at the Institute of Health and Medicine at the University of Linkoping, Sweden (2018), a position he still holds today. As part of his work with the CFSM, Christos has been involved as PI and collaborator in multiple large European and international research collaboratives and research proposals funded by the EU and international agencies. His work has focused on capacity building of primary health care and public health in Greece and internationally. Christos has a passion for education and has played a vital role in developing medical training, continuing medical education, and quality standards in primary care and public health nationally. Christos is also involved in an editorial and advisory capacity with several international journals. He also is a member of the Executive Board of various professional organisations including that of WONCA Working Party on Mental Health, where he is currently serving as Chair. He has been awarded as an Honorary Fellow for the Royal College of General Practitioners (2009), the World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians (WONCA) (2016), and the European Society of Cardiology (2017). Christos has published 444 papers in international journals that they cited in PubMed with a h-index of 63, a total i10 index of 340, and a total citation of 40044 (AD Scientific Index 21 January 2024). Between 2019 and 2022, Christos has served as a member of the European Commission Expert Panel on Effective Ways of Investing in Health, while he serves the Specific Advisory Group of the European Medicines Agency (EMA) until today. He is also a member of the National Committee for Mental Health Reform and Bioethics and Biotechnology since 2022.